PolarityTE Inc.

PolarityTE — Investor Presentation (January 2018)

29 slides from PolarityTE's investor presentation, Jan 9, 2018

  1. Slide 1: PolarityTE: where self regenerates self

  2. Slide 2: Forward Looking Statements

    Pag FORWARD LOOKING STATEMENTS Ls This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and complete

  3. Slide 3: The Problem with Regenerative Medicine is Tissue Engineering

    The Problem with Regenerative Medicine—is Tissue Engineering

  4. Slide 4: The Problem with Tissue Engineering

    The Problem with Tis The Tissue Engineering Triad Overly Reductionist Approaches to Myopic Theories SIGNALING | (@3, POGF. BHP) Keratinocytes ‘Skin Biopsy —» Ceil Isolation Y ME APPROPRIATE y REGENERATION ‘OF Tissue/ “ORGANS eg, omeobiasts Rorotiaets) Bere Allogenic | Triads, Single Cell Suspension

  5. Slide 5: The Solution to Regenerative Medicine is Polarity

    The Solution to Regenerative Medicine—is Polarity Polarized Interfaces Drive Embryogenesis, Histogenesis and Tissue Regeneration -larsi-ty: the tendency of living organisms or parts to REDEE is Ue LCEE on en | i and lowermost) ends, or to grow of orient ina particular direction. Polarity = Dynamic I

  6. Slide 6: PolarityTE - Welcome to the SHIFT

    PolarityTE™ - Welcome to the SHIFT™ a EVOLVING TECHNOLOGY PLATFORMS AND PRODUCTS Weare a clinical stage, commercial biotechnology and regenerative materials company a 4 with new and expanding technology platforms which are utilized to create functionally- \ polarized tissues for use in clinical medi

  7. Slide 7: SkinTE - Now Commercially Available and in Use Nationwide

    SkinTE™- Now Commercially Available and in Use Nationwide SkinTE™ is intended to be used by physicians or other appropriate healthcare providers for homologous uses of the skin and integumentary system. Patients who have suffered from an event, disease, process or who have an acquired defect that ha

  8. Slide 8: PolarityTE Tackles the Regenerative Wound Care Market

    PolarityTE™- Tackles the Regenerative Wound Care Market Current markets remain untapped with myopically-redundant and synthetic forms of tissue engineering products which do not utilize the functional and inherently regenerative tissues of the patient Global markets for tissue engineering and regene

  9. Slide 9: SkinTE - A Simple Process for an Exceptional Product

    | SkinTE™- A Simple Process for an Exceptional Product A Product for All Medical Providers Surgeons, Medical Doctors, Physician Assistants, Nurses, Wound Care Providers, Medics Patient Wounds Acute wounds, chronic wounds, acute burns, burn reconstruction, scar revision, surgical reconstruction, repl

  10. Slide 10: ai)

    ai)

  11. Slide 11: PolarityTE Real-Time Assistant App

    PolarityTE™ Real-Time Assistant App PolarityTE RTA

  12. Slide 12: A Proven Concept and an Evolving Tangible Technology

    | A Proven Concept and an Evolving Tangible Technolog EXPERIMENTAL EXPERIMENTAL ‘Transplantation of the LGR6’ Epithelial Stem “ell into Full-Thickness Cutaneous Wounds Results in Enhanced Healing, Nascent Hair Follicle Development, and Augmentation Stimulation of the Follicular Bulge LGR5' and LGR6'

  13. Slide 13: The Conventional Therapies and Fundamental Limitations

    The Conventional Therapies and Fundamental Limitations |

  14. Slide 14: Conventional Therapies and Fundamental Limitations

    pies and mental Limitati + Acellular scaffolds or matrices lack the innate ability to regenerate tissue and rely on surrounding tissue in-growth and ultimately secondary skin grafts for definitive coverage Allogeneic/Xenogeneic Cells: ic (tissue or cells derived from another person) or Xenograft (an

  15. Slide 15: Conventional Therapies and their Fundamental Limitations

    pies and their Fundamental Limitations A Massive Market Saturated with Stagnant Products Lacking \[E Fundamental Principles and Building Blocks for True Functional Skin Regeneration Regenerative Cellular Regenerates Full -Thickness Company Cellular Tissue Source Stem Cell Architecture Functional Ski

  16. Slide 16: The SkinTE Difference: Skin Regenerates Skin

    The SkinTE™ Difference Simply Put—Skin Regenerates Skin Embracing Complex Simplicity While other conventional regenerative medicine, cell therapy and tissue engineering companies and products try to reconstruct skin substitutes from a variety of cells, molecules, genes and scaffolds in order to circ

  17. Slide 17: Full-Thickness Skin Regeneration in Full-Thickness Wounds

    Full-Thickness Skin Regeneration in Full-Thickness Wounds Control W orld's First: PolarityTE™ Develops Full thickness Hair-Bearing Skin for Treatment of Burns, Wounds and Scars ploy {sults in Progres 6 Full-thickness Functionally-Polarized Skin ‘SkinTE™ Expands, into Residual Sear Regions e » 4 Comp

  18. Slide 18: Comparing the Clinical Standard of Care to SkinTE

    Comparing the Clinical Standard of Care to SkinTE™ Native Scar Healed Wound _Native Skin Full-Thickness Allograft Autograft \\\ Margin Native skin t Skin defects heal through a process of wound contraction and often scar formation. While skin grafts reduce contraction, patients still have scars. Ski

  19. Slide 19: SkinTE - Mid-Stage Intelligent and Dynamic Healing

    SkinTE™- Mid-Stage Intelligent and Dynamic Healing tage Native Contracting Wound SkinTE™ Mid-Stage Regenerative Wou a Contraction and Migration pitta gration Coturane Convergence with Native Sn i; Native Healed and Contracted Wound ¢ < Pseudo epithelium Covering the Underlying Sear SkinTE™ Regenerat

  20. Slide 20: Our Technology Platforms

    Pp Our Technology Platforms TheCore “TE” Products “TE” technology was discovered through careful observation and the study of neogenesis within systems, regenerative tissue healing and cellular propagation mechanisms in real-time. With this, the PolarityTE™ core “TE” platform technology has develope

  21. Slide 21: The Core TE Advantage - Complex Simplicity Made Reality

    The Core “TE” Advantage- Complex Simplicity Made Reality Autologous—From the Patient for the Patient: The immune system is highly complex and has evolved to recognize anything that is not truly self.” Our foundational platform is built on using autologous tissue(s), avoiding allogeneic tissue reject

  22. Slide 22: The Core TE Product Line - Simply Intuitive Product

    The Core “TE” Pro ine - Simply Intuitive Product Preclinical Development Clinical Deployment Tissue Product Ex Vivo Optimization Prototype Modeling Studies Market Entry & Commercialization 2H2017 2H 2017 L 2H 2018 2H 2018 BD polarityte Development Pipeline of PdlarityTE Core “TE” Products. A pipelin

  23. Slide 23: OsteoTE: Regeneration of Full-Thickness Bone Defects

    OsteoTE™: Regeneration of Full-Thickness Bone Defects é¥ OS PEE Oste6lE Welcome to the Shift™ Craniofacial=Spine—Long Bone Joints Hand Dental a “a de

  24. Slide 24: SkinTE Commercial Launch Triggered

    ‘SkinTE™ Commercial Launch Triggered PolarityTE™ Growth- Public, Commercial, Scaling and Evolving 2 Clinical application initiated across all wound types: ® Chronic wounds, reconstructive wounds, acute burns, surgical wounds Scar revision: Removal of healed standard of care skin grafts and replaceme

  25. Slide 25: The PolarityTEAM - Executive Management

    The PolarityTEAM - Executive Management Di Ne + Denver Lough, MD, PhD Edward Same = a tree aes, ‘Cameron Hoyler J.D. Chief Erect Office & Chairman Executive Vice President Executive Vice Presifent ie Legal Officer General Course Inventor/innovator behind patented BAS trom University of Pennsytvania:

  26. Slide 26: The PolarityTEAM - Board of Directors

    The PolarityTEAM - Board of Directors =>. ae... Chairman & Chief Executive Officer Edward (Ned) Swanson, MD Executive Vice President, COO, Director John Stetson Executive Vice President, CFO, Director Corporation, Medicis Pharmaceutical Corporation (acquired by Valeant for $2.6B), EntreMed, Inc., MR

  27. Slide 27: Medical Advisory Board

    cal Advisory Board

  28. Slide 28: We are PolarityTE - And Welcome to the SHIFT

    We are PolarityTE™-And Welcome to the SHIFT™ PolarityTE™, Inc. (NASDAQ: COOL) The New Paradigm of Regenerative Medicine is Here And This Time it is Real with a Proven Platform Technology A Regenerative Medicine Company Like No Other A revolutionary and proprietary platform technology developing prod

  29. Slide 29: Contact PolarityTE

    Contact PolarityTE™ Corporate Contact PolarityTE™ Support Contact PolarityTE™ Investor Relations Website: www.PolarityTE.com Customer Service: (800) 560-3983 John Stetson CFO Email: ParadigmShift@PolarityTE.com CustomerService@PolarityTE.com _ Investor Relations: (385) 560-3983 InvestorRelations@Pol

PolarityTE — Investor Presentation (January 2018) on 6ix